IP Library Granted Patent US 8,449,878
Granted Patent B2
US 8,449,878 · App. 13/118,613 · Granted May 28, 2013

Prebiotic formulations for use with probiotics to increase probiotic growth rate and activity

Inventors: Sonja Lea Yonak (Prior Lake, MN); Randolph S. Porubcan (Victoria, MN)
Assignee: Master Supplements, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,449,878
App. No.
13/118,613
Granted
May 28, 2013
Kind
B2
Abstract

Naturally occurring lecithins and/or oleic acid stimulate the growth and lactic acid producing activity of Lactobacillus and Bifidobacterium species of probiotic bacteria, and replace polysorbate 80 for those products. They can be used in naturally occurring form, or where they are to be combined with probiotics in a carrier, or they can be treated to yield a stable powdered form of these naturally oily compounds. They can be sold as combined prebiotic/probiotic formulations in the same carrier, or sold as separate dietary supplements, e.g., in capsule or tablet form, to be used with the probiotic formulation as desired.

Claims (26)

1. A prebiotic formulation for stimulating the growth and lactic acid producing activity of Lactobacillus or Bifidobacterium species of probiotic bacteria comprising:

a dry powdered form formulation of sunflower lecithin, or combinations of sunflower lecithin and oleic acid; and

wherein the formulation is substantially free of polysorbate 80.

2. The formulation of claim 1 further including Vitamin E.

3. The method formulation of claim 1 wherein the weight ratio of the sunflower lecithin lecithin's to oleic acid is from 60:40 to 95:5.

4. The formulation of claim 1 , in a caplet or capsule.

5. The formulation of claim 2 , wherein Vitamin E is the D, L or a mixture of the D and L isomers.

6. The formulation of claim 2 , wherein the Vitamin E is 0.05 to 2% by weight of the formulation.

7. The formulation of claim 3 , wherein the ratio of sunflower lecithin to oleic acid is 90:10.

8. The formulation of claim 4 , wherein the caplet or capsule has an enteric coating.

9. A dry powdered form prebiotic formulation for stimulating the growth and lactic acid producing activity of Lactobacillus or Bifidobacterium species of probiotic bacteria comprising:

a dry powdered form formulation of sunflower lecithin or oleic acid, or combinations of sunflower lecithin and oleic acid, adsorbed to an adsorbent which is one or more of calcium silicate, silicon dioxide, silica, clays and food starches, and mixed with microcellulose and silica; and

wherein the formulation is substantially free of polysorbate 80.

10. The formulation of claim 9 , wherein the sunflower lecithin or oleic acid, or the combinations of sunflower lecithin and oleic acid, are non-aqueous.

11. The formulation of claim 9 , wherein the sunflower lecithin or oleic acid, or the combinations of sunflower lecithin and oleic acid, are in a capsule, caplet, tablet or other carrier together with Lactobacillus and/or Bifidobacterium species.

12. The formulation of claim 9 , wherein the food starches are corn starch or potato starch.

13. The formulation of claim 9 , wherein the clays are food grade.

14. The formulation of claim 9 , wherein the microcrystalline cellulose carrier is between 10% to 300% of the weight of the adsorbent.

15. The formulation of claim 9 , wherein the combined weight of the lecithin and oleic acid is 5 to 40% of the weight of the formulation.

16. The formulation of claim 9 , wherein the silica is 0.25% to 2.0% by weight of the formulation.

17. The formulation of claim 9 wherein the weight ratio of the sunflower lecithin to oleic acid is from 60:40 to 95:5.

18. The formulation of claim 11 , wherein the strains of Lactobacillus include Lactobacillus acidophilus NCFM, Lactobacillus rhamnosus Lr-32, Lactobacillus paracasei Lpc-37, 25 and Lactobacillus salavarius Ls-33.

19. The formulation of claim 11 , wherein the Bifidobacterium is Bifidobacterium lactis B1-04 (BL-34).

20. The formulation of claim 11 , wherein the tablet, caplet, capsule or carrier has an enteric coating.

21. The formulation of claim 13 , wherein the clays are kaolin or sodium bentonite.

22. The formulation of claim 17 , wherein the ratio of sunflower lecithin to oleic acid is 90:10.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2013
From: PORUBCAN, RANDOLPH S.
To: MASTER SUPPLEMENTS, INC.
Reel/Frame 030282/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2013
From: YONAK, SONJA L.
To: MASTER SUPPLEMENTS, INC.
Reel/Frame 030282/0708 →
Continuity (2)
Provisional Application 61363172 · Jul 9, 2010
Related Publication 20120009239A1 · Jan 12, 2012